
New Data Links GLP-1 Drugs to Nail Detachment and Hair Loss
Two new studies presented at the European Academy of Dermatology and Venereology Congress indicate that users of GLP-1 receptor agonists, such as semaglutide and tirzepatide, experience significantly higher rates of hair loss and nail problems compared to non-users. While the findings show a strong association, experts emphasize that these issues may stem from rapid weight loss and nutritional deficiencies rather than the drugs themselves, and patients should not discontinue treatment without medical advice.













